Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trialDavid M. Charytan, Jonathan Himmelfarb, T. Alp İkizler et al.|Kidney International|2018Cited by 104
Evaluation of Screening Tests for Cognitive Impairment in Patients Receiving Maintenance HemodialysisDavid A. Drew, Mark J. Sarnak, Tammy Scott et al.|Journal of the American Society of Nephrology|2020Cited by 81
Blood Pressure and Cognitive Decline in Prevalent Hemodialysis PatientsDavid A. Drew, Mark J. Sarnak, Hocine Tighiouart et al.|American Journal of Nephrology|2019Cited by 13